Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · IEX Real-Time Price · USD
3.420
+0.020 (0.59%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $103.95 million as of July 26, 2024.
Market Cap
103.95M
Enterprise Value
-89.73M
1-Year Change
n/a
Ranking
Category
Stock Price
$3.42
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $103.95M, a decrease of -70.70%. That is a compound annual growth rate of -69.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 108.50M | -12.57% |
| Dec 29, 2023 | 124.10M | -65.02% |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cardiff Oncology | 101.52M |
| Omega Therapeutics | 101.49M |
| VistaGen Therapeutics | 99.56M |
| Aclaris Therapeutics | 98.35M |
| So-Young International | 96.15M |
| Xtant Medical Holdings | 94.46M |
| 111, Inc. | 94.07M |
| Checkpoint Therapeutics | 92.89M |